Studies young adults under 40 with melanoma skin cancer
Observes adults aged 18 to 39 with melanoma, looking at its features and risk factors.
Key facts
- Who runs it
- Ente Ospedaliero Ospedali Galliera
- Where
- Genoa, ItalySee the site
- Trial code
- Registry title
- Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
- Status
- Recruiting
- People taking part
- 25 people, planned
- Started
- 2 Dec 2025
- Expected to end
- 31 Aug 2028
- Type of study
- Observational
- Record updated
- 19 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 39 who have been diagnosed with melanoma of the skin. It is an observational study.
- Age
- 18 to 39 years
- Sex
- All sexes can join.
- Disease stage
- Diagnosis of cutaneous (skin) melanoma, even if it is not the first tumour (non-primary).
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- written informed consent
- age > 18 years and < 40 years
- diagnosis of cutaneous melanoma even non-primary
Who cannot take part
- -
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 39 years old?
Where in Italy
- E.O. Ospedali GallieraGenoa, ItalyContact: Sanja Javor, MDTaking people
About the trial
What the trial wants to find out
The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group.
Read full original descriptionShow less
Secondary objectives are the following:
* To identify risk factors associated with melanoma in young people. * To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years. * To analyse the relationship between the clinical and histopathological features of melanoma in young people. * To identify the mutational status of B-RAF in the sample of patients analysed.
The group in the trial
- ARM 1
Patients with melanoma diagnosis aged between 18 and 39 years.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Demographic, Clinical, Dermoscopic, Phenotypic and Genetic Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age. A Prospective, Monocentric Observational Study
- Plain-language title
- Studies young adults under 40 with melanoma skin cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06994208, who can take part
- Record updated
- 19 December 2025